Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases.

Jansen JF, Schöder H, Lee NY, Wang Y, Pfister DG, Fury MG, Stambuk HE, Humm JL, Koutcher JA, Shukla-Dave A.

Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1403-10. doi: 10.1016/j.ijrobp.2009.07.009. Epub 2009 Nov 10.

2.

Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.

Kim S, Loevner LA, Quon H, Kilger A, Sherman E, Weinstein G, Chalian A, Poptani H.

AJNR Am J Neuroradiol. 2010 Feb;31(2):262-8. doi: 10.3174/ajnr.A1817. Epub 2009 Oct 1.

3.

Proton and phosphorous MR spectroscopy in squamous cell carcinomas of the head and neck.

Chawla S, Kim S, Loevner LA, Quon H, Wang S, Mutale F, Weinstein G, Delikatny EJ, Poptani H.

Acad Radiol. 2009 Nov;16(11):1366-72. doi: 10.1016/j.acra.2009.06.001. Epub 2009 Jul 15.

4.

Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.

Dirix P, Vandecaveye V, De Keyzer F, Stroobants S, Hermans R, Nuyts S.

J Nucl Med. 2009 Jul;50(7):1020-7. doi: 10.2967/jnumed.109.062638. Epub 2009 Jun 12.

5.

Average arterial input function for quantitative dynamic contrast enhanced magnetic resonance imaging of neck nodal metastases.

Shukla-Dave A, Lee N, Stambuk H, Wang Y, Huang W, Thaler HT, Patel SG, Shah JP, Koutcher JA.

BMC Med Phys. 2009 Apr 7;9:4. doi: 10.1186/1756-6649-9-4.

6.

Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer.

Torizuka T, Tanizaki Y, Kanno T, Futatsubashi M, Naitou K, Ueda Y, Ouchi Y.

AJR Am J Roentgenol. 2009 Apr;192(4):W156-60. doi: 10.2214/AJR.08.1429.

PMID:
19304675
7.

The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL).

Noy A, Schöder H, Gönen M, Weissler M, Ertelt K, Cohler C, Portlock C, Hamlin P, Yeung HW.

Ann Oncol. 2009 Mar;20(3):508-12. doi: 10.1093/annonc/mdn657. Epub 2009 Jan 12.

8.

Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report.

Yao M, Smith RB, Hoffman HT, Funk GF, Lu M, Menda Y, Graham MM, Buatti JM.

Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):9-14. doi: 10.1016/j.ijrobp.2008.07.019. Epub 2008 Oct 17.

PMID:
18930358
9.

Tumor cell metabolism imaging.

Plathow C, Weber WA.

J Nucl Med. 2008 Jun;49 Suppl 2:43S-63S. doi: 10.2967/jnumed.107.045930. Review.

10.

Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer.

Ong SC, Schöder H, Lee NY, Patel SG, Carlson D, Fury M, Pfister DG, Shah JP, Larson SM, Kraus DH.

J Nucl Med. 2008 Apr;49(4):532-40. doi: 10.2967/jnumed.107.044792. Epub 2008 Mar 14.

11.

Correlation of positron emission tomography standard uptake value and pathologic specimen size in cancer of the head and neck.

Burri RJ, Rangaswamy B, Kostakoglu L, Hoch B, Genden EM, Som PM, Kao J.

Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):682-8. doi: 10.1016/j.ijrobp.2007.10.055. Epub 2008 Feb 6.

PMID:
18258379
12.

In vivo 1H magnetic resonance spectroscopy of lactate in patients with stage IV head and neck squamous cell carcinoma.

Le QT, Koong A, Lieskovsky YY, Narasimhan B, Graves E, Pinto H, Brown JM, Spielman D.

Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1151-7. doi: 10.1016/j.ijrobp.2007.11.030. Epub 2008 Feb 6.

13.

On the identifiability of pharmacokinetic parameters in dynamic contrast-enhanced imaging.

Lopata RG, Backes WH, van den Bosch PP, van Riel NA.

Magn Reson Med. 2007 Aug;58(2):425-9.

14.

Usefulness of standard deviation on the histogram of ultrasound as a quantitative value for hepatic parenchymal echo texture; preliminary study.

Lee CH, Choi JW, Kim KA, Seo TS, Lee JM, Park CM.

Ultrasound Med Biol. 2006 Dec;32(12):1817-26.

PMID:
17169693
15.

Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI.

Parker GJ, Roberts C, Macdonald A, Buonaccorsi GA, Cheung S, Buckley DL, Jackson A, Watson Y, Davies K, Jayson GC.

Magn Reson Med. 2006 Nov;56(5):993-1000.

16.

1H MR spectroscopy of the brain: absolute quantification of metabolites.

Jansen JF, Backes WH, Nicolay K, Kooi ME.

Radiology. 2006 Aug;240(2):318-32. Review.

PMID:
16864664
17.

Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.

Hylton N.

J Clin Oncol. 2006 Jul 10;24(20):3293-8. Review.

PMID:
16829653
18.

Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck.

Liauw SL, Mancuso AA, Amdur RJ, Morris CG, Villaret DB, Werning JW, Mendenhall WM.

J Clin Oncol. 2006 Mar 20;24(9):1421-7.

19.

The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.

Yao M, Smith RB, Graham MM, Hoffman HT, Tan H, Funk GF, Graham SM, Chang K, Dornfeld KJ, Menda Y, Buatti JM.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):991-9. Epub 2005 Aug 15.

PMID:
16099601
20.

FDG-PET prediction of head and neck squamous cell cancer outcomes.

Schwartz DL, Rajendran J, Yueh B, Coltrera MD, Leblanc M, Eary J, Krohn K.

Arch Otolaryngol Head Neck Surg. 2004 Dec;130(12):1361-7.

PMID:
15611393
Items per page

Supplemental Content

Write to the Help Desk